Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Leading MS pharmaceutical drugs in the U.S. by revenue 2013

Top 10 multiple sclerosis drugs worldwide by revenue in 2013 (in million U.S. dollars)

by Statista Research Department, last edited Feb 18, 2014
Leading MS pharmaceutical drugs in the U.S. by revenue 2013 This statistic displays the top 10 multiple sclerosis FDA-approved drugs based on revenues globally in 2013. During this year, Tecfidera (dimethyl fumurate), sponsored and developed by Biogen Idec, generated 876 million U.S. dollars in revenue. Tecfidera is used primarily for relapsing forms of MS. MS is a disease that damages nerve cells in the brain and spinal cord which disrupts the ability of the nervous system to communicate with the body.
Show more

Top 10 multiple sclerosis drugs worldwide by revenue in 2013 (in million U.S. dollars)

Product (Company)Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Product (Company)Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Feb 18, 2014
This statistic displays the top 10 multiple sclerosis FDA-approved drugs based on revenues globally in 2013. During this year, Tecfidera (dimethyl fumurate), sponsored and developed by Biogen Idec, generated 876 million U.S. dollars in revenue. Tecfidera is used primarily for relapsing forms of MS. MS is a disease that damages nerve cells in the brain and spinal cord which disrupts the ability of the nervous system to communicate with the body.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.